Atrophic dermatofibrosarcoma protuberans

Australasian Journal of Dermatology

Volumn 46, Issue 2, 2005, Pages 114-117

  Sinovich, Vania ^a,b   Hollowood, Kevin ^a   Burge, Susan ^a  

^a OXFORD UNIVERSITY HOSPITALS NHS FOUNDATION TRUST   (United Kingdom)

^b UNIVERSITY OF AUCKLAND   (New Zealand)

Author keywords

Atrophic plaque; CD34; Dermatofibroma

Indexed keywords

CD34 ANTIGEN;

ABDOMEN; ADULT; ARTICLE; ATROPHIC SKIN DISEASE; CASE REPORT; CELL NUCLEUS; CELL ULTRASTRUCTURE; CLINICAL FEATURE; CONSULTATION; DERMATOFIBROSARCOMA PROTUBERANS; DIFFERENTIAL DIAGNOSIS; FEMALE; FOLLOW UP; HISTOCHEMISTRY; HUMAN; PUNCH BIOPSY; SKIN BIOPSY; SPINDLE CELL; SYMPTOM;

ABDOMEN; BIOPSY; DERMATOFIBROSARCOMA; DIAGNOSIS, DIFFERENTIAL; FEMALE; HUMANS; MIDDLE AGED; SKIN NEOPLASMS;

EID: 18944392581     PISSN: 00048380     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1440-0960.2005.00156.x     Document Type: Article

References (13)

1. Young CR, Albertini MJ. Atrophic dermatofibrosarcoma protuberans: Case report, review and proposed molecular mechanisms. J. Am. Acad. Dermatol. 2005; 49: 761-4.
2. Gloster HM. Dermatofibrosarcoma protuberans. J. Am. Acad. Dermatol. 1996; 35: 355-74.
3. Lambert WC, Abramovits W, Gonzalez-Sevra A, Souehon E, Schwartz RA, Little WP Jr. Dermatofibrosarcoma non-protuberans: description and report of five cases of a morpheaform variant of dermatofibrosarcoma. J. Surg. Oncol. 1985; 28: 7-11.
4. Wu JK, Malik MM, Egan CA. Atrophic dermatofibrosarcoma protuberans: An uncommon and misleading variant. Australas. J. Dermatol. 2004; 45: 175-7.
5. Cavusoglu T, Yavuzer K, Tuncer S. Dermatofibrosarcoma protuberans of the breast. Aesthetic Plast. Surg. 2005; 27: 104-6.
6. Teixeira F, Devlin M, Hung N, Yun K. An atrophic plaque on the chest. Aust. Fam. Physician 2002; 51: 359-60.
7. Davis DA, Sanchez BL. Atrophic and plaquelike dermatofibrosarcoma protuberans. Am. J. Dermatopathol. 1998; 20: 498-501.
8. Weiss SW, Goldblum JR. Fibrohistiocytic tumors of intermediate malignancy. In: Enzinger FM, Weiss SW (eds). Soft Tissue Tumors, 4th edn. St Louis: CV Mosby, 2001; 491-534.
9. Zelger BW, Ofner D, Zelger BG. Atrophic variants of dermatofibroma and dermatofibrosarcoma protuberans. Histopathology 1995; 26: 519-27.
10. Simon M-P, Navarro M, Roux D, Pouyssegur J. Structural and functional analysis of a chimeric protein COL1A1-PDGFB generated by translocation I (17;22) (q22;13.1) in dermatofibrosarcoma protuberans. Oncogene 2001; 20: 2965-75.
11. Sjoblom T, Shimizu A, O'Brien KP, Pietras K, Dal Cin P, Buchdunger E, Dumanski JP, Ostman A, Heldin CH. Growth inhibition of dermatofibrosarcoma protuberans tumours by the platelet-derived growth factor receptor antagonist STI571 through induction of apoptosis. Cancer Res. 2001; 61: 5778-83.
12. Gloster HM, Harris KR, Roenigk RK. A comparison between Mohs micrographic surgery and wide surgical excision for the treatment of dermatofibrosarcoma protuberans. J. Am. Acad. Dermatol. 1996; 35: 82-7.
13. Ratner D, Thomas CO, Johnson TM, Sondak VK, Hamilton TA, Nelson BR, Swanson NA, Garcia C, Clark RE, Grande DJ. Mohs micrographic surgery for the treatment of dermatofibrosarcoma protuberans. J. Am. Acad. Dermatol. 1997; 37: 600-13.